Citigroup Inc Charles River Laboratories International, Inc. Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Citigroup Inc holds 35,838 shares of CRL stock, worth $6.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,838

Previous 146,597 75.55%

Holding current value

$6.06 Million

Previous $22.2 Million 74.79%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$145.57 - $178.99 $16.1 Million - $19.8 Million	-110,759 Reduced 75.55%	35,838 $5.61 Million
Q2 2025 Aug 11, 2025	SELL	$99.75 - $151.89 $8.77 Million - $13.4 Million	-87,913 Reduced 37.49%	146,597 $22.2 Million
Q1 2025 May 12, 2025	SELL	$150.52 - $190.14 $1.53 Million - $1.93 Million	-10,150 Reduced 4.15%	234,510 $35.3 Million
Q4 2024 Feb 12, 2025	BUY	$178.58 - $220.69 $1.52 Million - $1.88 Million	8,519 Added 3.61%	244,660 $45.2 Million
Q3 2024 Nov 12, 2024	BUY	$187.96 - $245.29 $4.28 Million - $5.59 Million	22,788 Added 10.68%	236,141 $46.5 Million
Q2 2024 Aug 12, 2024	BUY	$206.39 - $268.73 $2.22 Million - $2.89 Million	10,736 Added 5.3%	213,353 $44.1 Million
Q1 2024 May 10, 2024	BUY	$203.52 - $273.43 $4.26 Million - $5.72 Million	20,918 Added 11.51%	202,617 $54.9 Million
Q4 2023 Feb 09, 2024	BUY	$164.52 - $238.84 $15.7 Million - $22.7 Million	95,203 Added 110.07%	181,699 $43 Million
Q3 2023 Nov 09, 2023	BUY	$194.44 - $217.61 $12.8 Million - $14.3 Million	65,922 Added 320.41%	86,496 $17 Million
Q2 2023 Aug 10, 2023	SELL	$183.71 - $210.25 $1.68 Million - $1.92 Million	-9,146 Reduced 30.77%	20,574 $4.33 Million
Q1 2023 May 11, 2023	BUY	$191.89 - $259.92 $2.08 Million - $2.81 Million	10,830 Added 57.33%	29,720 $6 Million
Q4 2022 Feb 09, 2023	SELL	$197.11 - $250.07 $2.47 Million - $3.13 Million	-12,533 Reduced 39.88%	18,890 $4.11 Million
Q3 2022 Nov 10, 2022	BUY	$182.44 - $250.54 $2.37 Million - $3.26 Million	13,001 Added 70.57%	31,423 $6.19 Million
Q2 2022 Aug 10, 2022	SELL	$204.13 - $302.4 $845,710 - $1.25 Million	-4,143 Reduced 18.36%	18,422 $3.94 Million
Q1 2022 May 12, 2022	SELL	$255.51 - $362.11 $487,257 - $690,543	-1,907 Reduced 7.79%	22,565 $6.41 Million
Q4 2021 Feb 10, 2022	SELL	$351.38 - $448.68 $9.66 Million - $12.3 Million	-27,480 Reduced 52.89%	24,472 $9.22 Million
Q3 2021 Nov 10, 2021	BUY	$372.64 - $458.3 $19.4 Million - $23.8 Million	51,952 New	51,952 $21.4 Million

Others Institutions Holding CRL

# of Institutions

638

Shares Held

52.7M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.59B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account